yup... Cell Therapeutics (CTIC) Fails to Win US Panel's Backing for Pixuvri Injection 11:27 am ET 03/22/2010- StreetInsider Cell Therapeutics (Nasdaq: CTIC) fails to win US panel's backing for its Pixuvri injection. The FDA advisers voted 9-0 that Pixuvri data isn't sufficient.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.